Somil Mehta, Head of Retail Research at Mirae Asset ShareKhan, has issued specific stock recommendations for May 12, 2026. According to reports from The Times of India, the analyst has identified Max Healthcare Institute and Coal India as top buy candidates, while recommending AU Small Finance Bank as a sell opportunity.
Max Healthcare Institute has been recommended as a buy in the ₹1,040-₹1,041 range with a stop loss at ₹992 and target of ₹1,100. As reported by The Times of India, the analyst's recommendation proved prescient as the stock emerged as the second-biggest Nifty 50 gainer on Monday, rising 2.72% to close at ₹1,040 from its previous close of ₹1,012.50. The private hospital chain opened at ₹1,012.50, climbed steadily to an intraday high of ₹1,041.80, and sustained its gains through the session with a low of ₹1,003.85. A total of 30.43 lakh shares worth approximately ₹313.87 crore changed hands during the day, reflecting strong investor interest.
Coal India has been recommended as a buy in the ₹463-₹464 range with a stop loss at ₹442 and target of ₹500. According to The Times of India, the analyst's recommendation was also validated in Monday's trading session as Coal India was the third-biggest gainer on the Nifty 50, advancing 1.59% to close at ₹463.65 from its previous close of ₹456.40. The state-owned coal miner opened at ₹456, touched an intraday high of ₹465.75, and held its gains through the session with a low of ₹452.85. A total of 62.58 lakh shares worth approximately ₹288.89 crore were traded, demonstrating strong institutional participation.
The healthcare and FMCG sectors emerged as the primary beneficiaries of Monday's market rotation, with investors treating these defensive sectors as safe havens amid geopolitical turbulence stemming from the West Asia conflict. Tata Consumer Products topped the Nifty 50 gainers with an 8.05% surge to close at ₹1,270.90, while Sun Pharmaceutical advanced 1.47% to close at ₹1,875. The healthcare sector's outperformance was driven by its defensive nature, with pharmaceuticals drawing steady institutional flows even as benchmark indices came under pressure from geopolitical headwinds.
Coal India Ltd. presents a compelling valuation opportunity with a P/E ratio of 9.04 compared to the Minerals & Mining industry average of 10.59, representing a notable 15% discount. The stock, with a market capitalisation of ₹2,79,602.98 crores, offers a high dividend yield of 5.8% and has delivered strong long-term performance with 18.57% gains over the past year, significantly outperforming the Sensex's 3.78% decline. However, recent short-term momentum shows mixed signals with a 5.47% decline over the past week, though the stock remains above its key moving averages and maintains a 13.67% year-to-date gain.
